Epidemiology of ESBL-Producing Enterobacteriaceae, 2nd Edition
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: closed (30 November 2023) | Viewed by 1878
Special Issue Editor
Interests: staphylococcal infection; MRSA; molecular epidemiology E. coli infection; ST131 clone E. coli; community onset bacteremia; antimicrobial drug safety; infectious disease big data analytics; alternative therapy (phage and herb for MDR pathogen)
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The emergence of ESBL (extended spectrum beta-lactamase)-producing Enterobacteriaceae (or third-generation resistant cephalosporin) represents a challenge in the treatment of community-acquired and nosocomial infection. A higher percentage of ESBL-producing Enterobacteriaceae correlates with treatment failure and higher carbapenem use. Some research gaps have been noted in the epidemiology, risk factors and transmission model of ESBL-producing and MDR Enterobacteriaceae in different clinical settings. In addition, more data on animal and environment distribution are necessary. We welcome the submission of studies on the distribution and molecular characterization of antibiotic-resistant genes in ESBL-producing Enterobacteriaceae. Furthermore, studies on antibiotic utilization patterns in patients with infections or decolonization strategies in asymptomatic carriers would also be helpful to our readers.
Here is the link to the first edition: https://www.mdpi.com/journal/antibiotics/special_issues/epide_ESBL
Dr. Jiun-Ling Wang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- extended spectrum beta-lactamase
- enterobacteriaceae
- epidemiology
- risk factors
- antibiotic utilization patterns
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
